KCKatrina G. Claw

Katrina G. Claw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katrina G. Claw has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Erica L. Woodahl

    L.S. Skaggs Institute for Health Innovation University of Montana Missoula Montana USA

    3 shared publications
  • Krystal Sara Tsosie

    School of Life Sciences, Arizona State University, Tempe, Arizona, USA

    3 shared publications
  • Nanibaa' A. Garrison

    Institute for Society and Genetics, University of California, Los Angeles, Los Angeles, CA; Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA

    3 shared publications
  • Nanibaa’ A. Garrison

    Institute for Society and Genetics, the Institute for Precision Health, and the Division of General Internal Medicine & Health Services Research, University of California, Los Angeles, Los Angeles, USA

    3 shared publications
  • Ripan S. Malhi

    University of Illinois

    3 shared publications
  • Willie J. Swanson

    Department of Genome Sciences, University of Washington, Seattle, WA, USA

    3 shared publications

Latest Publications

  • Open Access

    Underrepresented voices in a Colorado Biobank: Perspectives from focus groups on motivations, return of results, and data sharing

    by Carissa A. Sherman, Betzaida L. Maldonado, Lucas O. Rozell, Sarah D. Slack, Isabella E. Eaton, Doreen E. Martinez, Randi K. Johnson, Katrina G. Claw

  • Open Access

    Virtual deliberation on genetics research: report-out of key themes from Diné (Navajo) research & healthcare professionals

    by Carissa A. Sherman, Luke C. Nez, Kaja M. Aagaard, Dalaki J. Livingston, Erika Blacksher, Justin Reedy, Vanessa Y. Hiratsuka, Walter Phelps, Jessica W. Blanchard, Justin R. Lund, et al.

    Various challenges including cultural concerns, the shortage of Diné (Navajo) scientists and scientists with cultural competence to engage with Diné communities, and the need for rigorous policies regarding genetic research led to the establishment of a moratorium on genetic research within the Navajo Nation in 2002. Previous surveys with Diné interest holders highlighted ongoing uncertainty about lifting the moratorium and underscored the need for further community consultation and education. Deliberative democratic engagement has been an effective approach for exploring Indigenous community values regarding genomic research. To assess perspectives on genetic research and inform future policy, we conducted a two-day virtual deliberation with 17 research and healthcare professionals associated with the Navajo Nation, including Diné (n = 15) and non-Diné (n = 2) deliberants. Deliberants varied in their knowledge of genetics (n = 5 reported knowing “a lot”; n = 12 “a little bit”), and a majority (n = 13) were aware of the moratorium. Two overarching themes, “life and history experiences” and “values,” emerged, reflecting how personal and professional backgrounds, alongside individual and collective standards, shaped deliberants’ views on genetic research and its practices. Subthemes within these categories offered deeper insights into their perspectives. Although deliberants expressed caution regarding exploratory genetic studies, there was interest in using genetic research to advance individualized healthcare. Deliberants’ concerns emphasized the need for a robust genetic research policy that prioritizes Diné culture, community interests, public health and wellbeing, and the sovereignty of the Navajo Nation.


  • Open Access

    Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community

    by Madeline L. Wichman, Daniela M. Wall, Suzanna S. Garcia Mota, Shayna R. Killam, Karen E. Brown, Kaja Aagaard, Juanita Swaney, LeeAnna I. Muzquiz, Bernadette N. Corum, Katrina G. Claw, et al.

    Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application to diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community‐centric study aims to understand perspectives on utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant (n = 273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of the risks associated with tobacco usage and believed it to be a problem within their community (76%). Our results showed that 29% of participants had some level of knowledge regarding pharmacogenomics and only 6% had previously participated in pharmacogenomics research, demonstrating the need for further education and awareness. Community involvement was a priority for participants, with 64% preferring Tribal inclusion in all research stages and 63% favoring partnerships with local health centers. We also found support for future research, with 68% viewing pharmacogenomics as a beneficial tool. Concerns were raised regarding the handling of genetic material and result dissemination, emphasizing the importance of ethical research practices, transparent communication, and community partnership. Our findings serve as a foundation for shaping future research efforts and developing a framework for implementing tobacco cessation interventions. Our community‐centered approach addresses the specific needs of this AIAN community and offers insights applicable to research practices within other underserved and marginalized populations, particularly those with a historical distrust of research.


  • Open Access

    Implementing community-engaged pharmacogenomics in Indigenous communities

    by Katrina G. Claw, Casey R. Dorr, Erica L. Woodahl

    Innovative pharmacogenomic approaches (genetic variation related to medication response) are needed to reduce disease and disparities in Indigenous communities. We support community-based pharmacogenomics research, inclusive of Indigenous values and priorities, to improve the health and well-being of Indigenous peoples.


  • Indigenous diversity in Australia’s DNA tapestry unlocked for genetic equity

    by Katrina G. Claw, Amber Nashoba

    Diverse genomic sequences might boost equity in areas such as health care. Genomic data from Indigenous Australians, shared through a community-consultation framework, aids efforts to boost genetic representation. Genomic data that might boost equity in areas such as health care.


  • Open Access

    Pharmacogenetic Variation in Neanderthals and Denisovans and Implications for Human Health and Response to Medications

    by Tadeusz H Wroblewski, Kelsey E Witt, Seung-Been Lee, Ripan S Malhi, David Peede, Emilia Huerta-Sánchez, Fernando A Villanea, Katrina G Claw

    Modern humans carry both Neanderthal and Denisovan (archaic) genome elements that are part of the human gene pool and affect the life and health of living individuals. The impact of archaic DNA may be particularly evident in pharmacogenes—genes responsible for the processing of exogenous substances such as food, pollutants, and medications—as these can relate to changing environmental effects, and beneficial variants may have been retained as modern humans encountered new environments. However, the health implications and contribution of archaic ancestry in pharmacogenes of modern humans remain understudied. Here, we explore 11 key cytochrome P450 genes (CYP450) involved in 75% of all drug metabolizing reactions in three Neanderthal and one Denisovan individuals and examine archaic introgression in modern human populations. We infer the metabolizing efficiency of these 11 CYP450 genes in archaic individuals and find important predicted phenotypic differences relative to modern human variants. We identify several single nucleotide variants shared between archaic and modern humans in each gene, including some potentially function-altering mutations in archaic CYP450 genes, which may result in altered metabolism in living people carrying these variants. We also identified several variants in the archaic CYP450 genes that are novel and unique to archaic humans as well as one gene, CYP2B6, that shows evidence for a gene duplication found only in Neanderthals and modern Africans. Finally, we highlight CYP2A6, CYP2C9, and CYP2J2, genes which show evidence for archaic introgression into modern humans and posit evolutionary hypotheses that explain their allele frequencies in modern populations.


  • Open Access

    Ethical Guidance in Human Paleogenomics: New and Ongoing Perspectives

    by Raquel E. Fleskes, Alyssa C. Bader, Krystal S. Tsosie, Jennifer K. Wagner, Katrina G. Claw, Nanibaa’ A. Garrison

    Over the past two decades, the study of ancient genomes from Ancestral humans, or human paleogenomic research, has expanded rapidly in both scale and scope. Ethical discourse has subsequently emerged to address issues of social responsibility and scientific robusticity in conducting research. Here, we highlight and contextualize the primary sources of professional ethical guidance aimed at paleogenomic researchers. We describe the tension among existing guidelines, while addressing core issues such as consent, destructive research methods, and data access and management. Currently, there is a dissonance between guidelines that focus on scientific outcomes and those that hold scientists accountable to stakeholder communities,such as descendants. Thus, we provide additional tools to navigate the complexities of ancient DNA research while centering engagement with stakeholder communities in the scientific process.


  • Open Access

    Perspectives on Genetic Research: Results From a Survey of Navajo Community Members

    by Katrina G. Claw, Nicolas Dundas, Michael S. Parrish, Rene L. Begay, Travis L. Teller, Nanibaa’ A. Garrison, Franklin Sage

    The Navajo Nation placed a moratorium on genetic research studies in 2002, in part due to concerns about historical distrust, exploitation, limited expertise and resources, and the lack of a genetics policy. Navajo tribal leaders, scientists, and policy experts are exploring the possibility of lifting the moratorium, developing a genetic research policy, and discussing its potential health implications. This study aimed to identify the key concerns, needs, and desires of Navajo people regarding genetic research. We conducted a survey of Navajo individuals to assess knowledge of the moratorium and research, gauge interest in genetic research, and quantify appropriate genetic research topics to understand broad views and concerns. We performed descriptive statistics and tested associations between relevant categorical variables using Chi-square tests. We hypothesized that individuals with more knowledge about the moratorium and health research increased the likelihood of supporting and participating in genetic research. A total of 690 surveys from Navajo respondents were analyzed. Of these, 63% of respondents reported being unaware of the Navajo Nation’s moratorium on genetic research. There were positive associations between those who knew about the moratorium and willingness to donate biospecimens for research under certain conditions, such as community involvement, review and approval by community leaders, research on diseases affecting the community, and support for lifting the moratorium (p-values < 0.001). We found no significant differences between age, gender, religious/spiritual beliefs, or agency affiliation with knowledge levels of genetics and related topics, participation in relation to beliefs, and donation of biospecimens. Interestingly, respondents who resided off the Navajo Nation were positively associated with having knowledge of the moratorium, having heard of discussions of genetics on the Navajo Nation, and the lawsuit filed by the Havasupai Tribe. Most respondents agreed that it was very important to develop a policy that incorporates cultural knowledge (56%), is beneficial (56%), and has data sharing protections (59%) before allowing genetic research on the Navajo Nation. Overall, a large proportion of respondents (46%) were unsure about lifting the moratorium and instead wanted more genetics education to assess its potential implications. The study results can inform the direction of future guidelines and policies.


  • Open Access

    Pharmacogenetic variation in Neanderthals and Denisovans and implications for human health and response to medications

    by Tadeusz H. Wroblewski, Kelsey E. Witt, Seung-Been Lee, Ripan S. Malhi, Emilia Huerta-Sanchez, Fernando Villanea, Katrina G. Claw

    Modern humans carry both Neanderthal and Denisovan (archaic) genome elements that are part of the human gene pool and affect the life and health of living individuals. The impact of archaic DNA may be particularly evident in pharmacogenes – genes responsible for the processing of exogenous substances such as food, pollutants, and medications. However, the health implications and contribution of archaic ancestry in pharmacogenes of modern humans remains understudied. Here, we explore eleven key cytochrome P450 genes ( CYP450 ) involved in drug metabolizing reactions in three Neanderthal and one Denisovan individuals as well as examine archaic introgression in modern human populations. We infer the metabolizing efficiency of these eleven CYP450 genes in archaic individuals and find important phenotypic differences relative to modern human variants. We identify several single nucleotide variants shared between archaic and modern humans in each gene, including some potentially function-altering mutations in archaic CYP450 genes, which may result in altered metabolism in living people carrying these variants. We highlight three genes which show evidence for archaic introgression into modern humans, as well as one additional gene that shows evidence for a gene duplication found only in Neanderthals and modern Africans.